Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Survival time in dogs with non-treated nasal carcinomas
Not all owners of dogs with malignant nasal tumors agree to perform surgery, radiation or chemotherapy. Less is known about the survival time of dogs receiving no or only palliative therapy. A large and very informative study provides more informations to give to the owners of affected dogs.

the objective of the retrospective study was to evaluate factors associated with survival in dogs with nasal carcinomas that did not receive treatment or received only palliative treatment. 139 dogs with histologically confirmed nasal carcinomas were included.

Medical records, computed tomography images, and biopsy specimens of nasal carcinomas were reviewed.

Only dogs that were not treated with radiation, surgery, chemotherapy, or immunotherapy and that survived > or = 7 days from the date of diagnosis were included.

The Kaplan-Meier method was used to estimate survival time.

Factors potentially associated with survival were compared by use of log-rank and Wilcoxon rank sum tests.

Multivariable survival analysis was performed by use of the Cox proportional hazards regression model.

RESULTS: Overall median survival time was 95 days (95% confidence interval [CI], 73 to 113 days; range, 7 to 1,114 days). In dogs with epistaxis, the hazard of dying was 2.3 times that of dogs that did not have epistaxis.

Median survival time of 107 dogs with epistaxis was 88 days (95% CI, 65 to 106 days) and that of 32 dogs without epistaxis was 224 days (95% CI, 54 to 467 days).

CONCLUSIONS AND CLINICAL RELEVANCE: The prognosis of dogs with untreated nasal carcinomas is poor. Treatment strategies to improve outcome should be pursued.



Source: Rassnick KM, et al (2006): Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003). In: J Am Vet Med Assoc. 2006 Aug 1;229(3):401-6.




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Use of a Surgical Safety Checklistmembers
Does the use of a surgical safety checklist (SSC)reduce the incidence of complications after small animal surgery? This is the question which the new study enrolling more than 500 patients tries to answer.

  • NGAL in dogs with chronic kidney diseasemembers
  • Long-term Outcome of Irish Wolfhound Dogs with different heart medicationsmembers
  • Simple technique for autotransfusion in dogsmembers
  • General anesthesia with an injectable 8% v/v sevoflurane lipid emulsion in dogsmembers
  • Carboplatin sustained-release delivery system in dogs with cancermembers
  • Wound bio-burden and prevalence of multi-drug resistant bacteria in open woundsmembers
  • Concurrent perioperative use of marbofloxacin and cimicoxib or carprofenmembers
  • Topical hyaluronic acid and the corneal wound healing members
  • Moraxella phenylpyruvica infection leading to severe heart problems in an old dogmembers
  • Propofol versus propofol-alfentanil admixture for sedation in dogsmembers
  • Second-Generation NT-proBNP Measurements in Catsmembers
  • Cobalamin and Methylmalonic Acid Concentrations in Hyperthyroid Cats Before and After Therapymembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved